macrohaematuria occurred in 0.8% (9/1090). The incidence of small, haemodynamically irrelevant AV
Introduction
Biopsies were performed only if patients were strictly normotensive (<140/90 mmHg) and had normal Renal biopsy is the diagnostic procedure of choice in coagulation parameters (PT, PTT, factor VIII, thrommany patients in whom renal disease is suspected. Like bocyte count, and bleeding time). All patients had every invasive procedure, renal biopsy is fraught with been advised not to take aspirin or non-steroidal antipotential complications. inflammatory agents for at least 5 days prior biopsy.
With the introduction of the ultrasound-guided We analysed (1) yield of diagnostically useful material, biopsy renal biopsy has become easier and safer [1,2] and (2) frequency of postbiopsy complications (e.g. compared to the presonography era, and a further step macrohaematuria, haematoma, infections, and AV forward was the introduction of an automated springfistula).
loaded biopsy device [3, 4] .
Results. Except for one case requiring interventional
Although compared to the Tru-Cut or Vimradiology because of persisting blood loss and three Silvermann device the needle used with the BioptyA cases requiring blood transfusions, no serious comtechnique is narrower (18 gauge=1.2 mm) so that plications were seen in the 1090 consecutive renal less tissue is obtained, the number of glomeruli per biopsies, e.g. death, loss of kidney, life-threatening biopsy specimen is apparently still sufficient for histohaemorrhage, or persisting haemodynymically relevant pathological diagnosis in most cases. AV fistulae.
Information on the efficacy and safety of renal The frequency of minor haematoma with an biopsy with the spring-loaded BioptyA device is of extension >2×2 cm, but no significant decrease of interest for cost benefit calculations regarding the haemoglobin, was 2.2% (25/1090). Self-limited mild indication of renal biopsy [5] , for medicolegal purposes, and for other reasons. To obtain such O. Hergesell et al. 976 Biopsy was performed in prone position with patients
Subjects and methods
lying with the abdomen on a firm pillow. The lower pole of the kidney was located by ultrasound and the site of insertion The analysis concerned 1090 consecutive ultrasound-guided of the biopsy needle was marked with ink. The most appropercutaneous renal biopsies that were performed in the renal priate needle-skin angle was selected by adjusting the units of Heidelberg and Karlsruhe from January 1993 to puncturing adaptor (usually 65°). June 1997.
After disinfection of the skin (FrekadermA, Fresenius, Bad The demographic data and the diagnostic categories of the Homburg, Germany) lignocaine (1%) was applied locally patients are listed in Table 1 . To minimize the risk of bleeding under ultrasound control along the needle insertion tract. complications the following precautions were routinely taken.
To facilitate introduction of the biopsy needle a small Coagulation parameters (prothrombin time, partial incision of the skin was made. Under visualization by ultrathromboplastin time, fibrinogen, and factor VIII ) were meas-sound the needle was advanced at an angle of 65°until the ured using standard methods in all patients prior to biopsy. capsule of the lower kidney pole had been reached. The (factor VIII was measured to rule out patients with overt patient was asked to hold his or her breath, the biopsy device haemophilia and patients with a subhaemophilic state). If was unlocked and tissue obtained. The sampling time was there were any abnormalities in coagulation tests that could <1 s. not be explained by reversible causes renal biopsy was not
The length of the obtained biopsy specimens was usually performed. All patients were asked to abstain from aspirin 18-20 mm in orthotopic kidney biopsies and 10-12 mm in or NSAIDs for at least 5 days before biopsy. Administration transplant biopsies. In the renal unit of Heidelberg at least of heparin was stopped on the day before biopsy. two biopsies were taken. Bleeding time (Ivy) was routinely measured in all patients After biopsy the patient was instructed to remain in bed on the morning of the scheduled renal biopsy to rule out for 24 h. Local pressure on the biopsy site was exerted with platelet dysfunction due to intrinsic causes (e.g. v. a pillow. Blood pressure and pulse were monitored at hourly Willebrand's disease) or extrinsic causes (aspirin or NSAIDs). intervals after biopsy. Four to six hours after the biopsy If biopsy was mandatory in a patient with suspected v. haematocrit and haemoglobin were measured. Willebrand's disease or prolonged bleeding time secondary
On the next morning patients were mobilized after ultrato uraemia, DDAVP (0.4 mg/kg body-weight) was adminis-sound examination had ruled out major haematoma. tered 2-3 h prior to the renal biopsy; this was done in three patients. Renal biopsy was not performed in patients who were hypertensive (>140/90 mmHg) at the time of the scheduled biopsy until the blood pressure had been lowered to the Results normotensive range.
To avoid technical difficulties and an increased risk of Only 1.2% of specimens showed no glomeruli (0.7%) bleeding, patients with renal cortex width <10 mm were not or even no renal tissue (0.5%). In all other cases considered suitable for renal biopsy. sufficient material could be detected. The median After the biopsy patients were asked to stay in the bed until sonographic examination the next morning. Patients number of glomeruli was 9 (range 1-37) per specimen. were usually hospitalized overnight and dismissed on the A histological analysis, including conventional light morning after the biopsy if no major haematoma was and immunofluorescence microscopy, could be made detected.
by the pathologist in 99.1% of the successful biopsies.
The complications of renal biopsy are listed in Table 2 .
Technical details
An automated spring-loaded biopsy device (BioptyA Radiplast AB, Uppsala, Sweden) was used.
Discussion
A 20-cm needle was used for biopsies of orthotopic kidneys and a 16-cm needle for transplant biopsies. The diameter of the needle was 1.2 mm (18 gauge). In all cases the caudal With the ultrasound-guided renal biopsy technique pole of the kidney was used for biopsy. Usually the biopsy using an automatic spring-loaded biopsy device, renal was performed on the left kidney. In cases with cysts, small biopsy has become safe and reliable. Burstein et al. [3] cortex, or medium-size arteries at the caudal pole of the left reported on 91 patients, who were biopsied with this kidney, the right kidney was biopsied. Single orthotopic device. They found complications in 14.3% of patients.
kidneys (anatomically or functionally) were not biopsied.
Of these 6.6% were minor (macrohaematuria not requiring transfusion) and 7.7% were major (bleeding Table 1 . Demographic data and diagnostic categories in 1033 renal requiring blood transfusion). There was no significant biopsy patients in two German renal units difference in complication rate compared to the use of a standard biopsy needle ( Tru-cut). The high incidence Heidelberg Karlsruhe of minor and major complications despite using the BioptyA device compared to our findings may be due Patients (n) 538 495 to the fact that they used a 14-gauge needle, whereas No major complications occurred. In one patient of (s-creatinine >5 mg/dl ) each series macrohaematuria was observed (4.8%).
Safety of ultrasound-guided percutaneous renal biopsy-retrospective analysis of 1090 consecutive cases 977 Mendelssohn and Cole [8] found an overall not restricted to one or two persons, but a very strict learning protocol has been established to guarantee complication rate of 5.3% in 544 consecutive percutaneous kidney biopsies (482 biopsies were performed that junior colleagues are thoroughly familiar with the technique once they begin to carry out biopsies, and with an automated core biopsy system). Transient gross haematuria occurred in 4.4% of their patients as biopsies are never performed without supervision of a senior nephrologist. opposed to 0.8% in the present series. It should be noted that the authors did not consistently biopsy with real time ultrasound control.
